CARDIOVASCULAR RISK FACTORS--CHRONIC RENAL INSUFFICIENCY
心血管危险因素——慢性肾功能不全
基本信息
- 批准号:6190250
- 负责人:
- 金额:$ 13.04万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2000
- 资助国家:美国
- 起止时间:2000-09-30 至 2005-08-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (adapted from the application)
Chronic renal disease is a major public health problem in the US.
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality.
Prevention of CVD in chronic renal disease requires early intervention, during
the stage of chronic renal insufficiency (CRI). The general hypothesis for the
proposed research program is that the progression of CVD and chronic renal
disease share common mechanisms; and that "traditional" and "uremia-related"
risk factors, in particular total plasma homocysteine (tHcy), lipoprotein(a)
(Lp(a)) and C-reactive protein (CRP), contribute to the progression of both CVD
and chronic renal disease.
The Principal Investigator (PI) has designed a rigorous training program that
will provide him with the necessary-skills, experience and opportunities to
develop into an independent investigator in the field of cardiovascular
epidemiology in chronic renal disease. He will obtain a Master's of Science in
Clinical Care Research, participate in projects utilizing a broad range of
study designs for clinical care research, and carry out an original research
project from its inception to completion. His mentors have extensive experience
in clinical investigation in nephrology, CVD epidemiology and clinical care
research methodology.
There are currently minimal data available on the incidence of CVD or the risk
factors for CVD in CRI. The Modification of Diet in Renal Disease (MDRD) Study
was the largest prospective study of patients with CRI, and is an ideal study
population for the proposed research. Specific aims are as follows: 1. Measure
tHcy, Lp(a), apo(a) isoforms and CRP levels from frozen samples taken at
baseline in the MDRD Study and characterize the distribution of levels and
their relationship to baseline glomerular filtration rate (GFR) and other
factors. 2. Determine whether baseline levels of tHcy, Lp(a), apo(a) isoforms
or CRP are predictors of subsequent GFR decline. 3. Resume contact with the
MDRD Study cohort, collect data on CVD and renal outcomes, and determine the
relationship of traditional and uremia-related risk factors to CVD and renal
outcomes. Statistical analysis reveals adequate power to evaluate each aim and
a pilot study has documented the feasibility of aim 3. The PI has assembled a
team of nephrologists, CVD epidemiologists, and nutrition scientists to assist
him in the conduct of the project; enlisted the collaboration of the MDRD Study
Data Coordinating Center, and organized internal and external advisory
committees to monitor his progress. The proposed L training program and
research project will prepare him for a career as an independent investigator.
描述(改编自应用程序)
慢性肾病是美国的一个主要公共卫生问题。
心血管疾病(CVD)是发病率和死亡率的主要原因。
慢性肾病的CVD预防需要早期干预,
慢性肾功能不全(CRI)阶段。一般假设为
拟议的研究计划是,CVD 和慢性肾病的进展
疾病有共同的机制;以及“传统”和“尿毒症相关”
危险因素,特别是血浆总同型半胱氨酸 (tHcy)、脂蛋白(a)
(Lp(a)) 和 C 反应蛋白 (CRP),有助于 CVD 的进展
和慢性肾脏疾病。
首席研究员 (PI) 设计了严格的培训计划
将为他提供必要的技能、经验和机会
发展成为心血管领域的独立研究者
慢性肾脏病的流行病学。他将获得理学硕士学位
临床护理研究,参与利用广泛的项目
临床护理研究的研究设计,并开展原创性研究
项目从开始到完成。他的导师拥有丰富的经验
肾脏病学、CVD流行病学和临床护理的临床研究
研究方法。
目前关于 CVD 发生率或风险的可用数据很少
CRI 中 CVD 的影响因素。肾脏疾病饮食调整 (MDRD) 研究
是 CRI 患者最大规模的前瞻性研究,也是一项理想的研究
拟议研究的人口。具体目标如下: 1. 措施
冷冻样本中的 tHcy、Lp(a)、apo(a) 同工型和 CRP 水平
MDRD 研究中的基线并描述水平的分布和
它们与基线肾小球滤过率(GFR)和其他因素的关系
因素。 2. 确定 tHcy、Lp(a)、apo(a) 同工型的基线水平是否
或 CRP 是随后 GFR 下降的预测因子。 3. 恢复与
MDRD 研究队列,收集 CVD 和肾脏结果数据,并确定
传统危险因素和尿毒症相关危险因素与心血管疾病和肾病的关系
结果。统计分析揭示了评估每个目标的足够能力
一项试点研究已经证明了目标 3 的可行性。PI 已编制了一份
由肾病专家、CVD流行病学家和营养科学家组成的团队提供协助
他参与项目的实施;获得 MDRD 研究的合作
数据协调中心,组织内外部咨询
委员会监督他的进展。拟议的 L 培训计划和
研究项目将使他为独立调查员的职业生涯做好准备。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MARK J SARNAK其他文献
MARK J SARNAK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MARK J SARNAK', 18)}}的其他基金
Does Raising HDL-C with Niacin Improve Endothelial Function in Early CKD?
用烟酸提高 HDL-C 是否可以改善早期 CKD 的内皮功能?
- 批准号:
7612743 - 财政年份:2008
- 资助金额:
$ 13.04万 - 项目类别:
Chronic Kidney Disease, Vascular Disease and Aging
慢性肾脏病、血管疾病和衰老
- 批准号:
7245470 - 财政年份:2007
- 资助金额:
$ 13.04万 - 项目类别:
Chronic Kidney Disease, Vascular Disease and Aging
慢性肾脏病、血管疾病和衰老
- 批准号:
7471547 - 财政年份:2007
- 资助金额:
$ 13.04万 - 项目类别:
Chronic Kidney Disease, Vascular Disease and Aging
慢性肾脏病、血管疾病和衰老
- 批准号:
7666280 - 财政年份:2007
- 资助金额:
$ 13.04万 - 项目类别:
Chronic Kidney Disease, Vascular Disease and Aging
慢性肾脏病、血管疾病和衰老
- 批准号:
8119736 - 财政年份:2007
- 资助金额:
$ 13.04万 - 项目类别:
KIDNEY DISEASE, VOLUME STATUS AND COGNITION IN AGING
肾脏疾病、体积状态和衰老认知
- 批准号:
7200880 - 财政年份:2005
- 资助金额:
$ 13.04万 - 项目类别: